US Map / Indiana
State IN

Clinical Trials in Indiana

Recruiting clinical trials with at least one study location in Indiana. Data updated daily from ClinicalTrials.gov.

Total Trials
171
Recruiting Now
171
← Back to US Map
Top Conditions in Indiana
Prostate Cancer (7)Breast Cancer (6)Malignant Solid Neoplasm (4)Melanoma (3)Ovarian Cancer (3)Endometrial Cancer (3)Acute Myeloid Leukemia (3)Atopic Dermatitis (3)Atrial Fibrillation (3)Lung Non-Small Cell Carcinoma (2)Non-small Cell Lung Cancer (2)Sarcoma (2)
NCT07160179 Phase 1, Phase 2
Recruiting
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through ...
Condition
Geographic Atrophy
Enrollment
66 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT06773962 Phase 2
Recruiting
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's ...
Condition
Parkinson's Disease (PD)
Enrollment
62 pts
Location
United States
Sponsor
TrueBinding, Inc.
View Trial →
NCT05381103 Phase 2, Phase 3
Recruiting
PSMA-PET to Guide Prostatectomy
Condition
Prostate Cancer
Enrollment
288 pts
Location
United States
Sponsor
Five Eleven Pharma, Inc.
View Trial →
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
View Trial →
NCT05481879 Phase 1, Phase 2
Recruiting
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DY...
Condition
Myotonic Dystrophy Type 1 (DM1)
Enrollment
116 pts
Location
United States, Australia, France
Sponsor
Dyne Therapeutics
View Trial →
NCT06445296 N/A
Recruiting
Postprandial Effects of Animal Versus Plant-Based Protein
Condition
Overweight or Obesity
Enrollment
30 pts
Location
United States
Sponsor
Ball State University
View Trial →
NCT04485013 Phase 1
Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Condition
Cancer
Enrollment
240 pts
Location
United States
Sponsor
Tizona Therapeutics, Inc
View Trial →
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT06625385 N/A
Recruiting
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dres...
Condition
Wound
Enrollment
90 pts
Location
United States
Sponsor
Solventum US LLC
View Trial →
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
View Trial →
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06777433 Phase 2
Recruiting
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain ...
Condition
Brain Metastases From Solid Tumors
Enrollment
30 pts
Location
United States
Sponsor
Radiopharm Theranostics, Ltd
View Trial →
NCT04811560 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Condition
Acute Leukemias
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT06667076 Phase 2
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combina...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
480 pts
Location
United States, Belgium, Finland
Sponsor
Janssen Research & Development
View Trial →
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT02708134 N/A
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Condition
Cardiac Arrest
Enrollment
7,000 pts
Location
United States, Australia, Brazil
Sponsor
Children's Hospital of Philade
View Trial →
NCT01719055 N/A
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-T...
Condition
Pain
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
Boston Scientific Corporation
View Trial →
NCT06484920 Phase 2
Recruiting
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatm...
Condition
Relapsed Hodgkin Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Rita Assi
View Trial →
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.
View Trial →
Page 7 of 7 — 171 trials total
← Prev